| Dr Ronald Anthony Shubert, MD | |
|
3501 Tuscarawas St W, Canton, OH 44708-5640 | |
| (330) 453-3099 | |
| (330) 453-3240 |
| Full Name | Dr Ronald Anthony Shubert |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Infectious Disease |
| Location | 3501 Tuscarawas St W, Canton, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467430934 | NPI | - | NPPES |
| 0223663 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 35-02-8483-S (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ronald Anthony Shubert, MD 3501 Tuscarawas St W, Canton, OH 44708-5640 Ph: (330) 453-3099 | Dr Ronald Anthony Shubert, MD 3501 Tuscarawas St W, Canton, OH 44708-5640 Ph: (330) 453-3099 |
News Archive
Challenging prevailing wisdom that only children with end-stage kidney disease suffer physical, social, emotional and educational setbacks from their disease, research led by Johns Hopkins Children's Center shows that even mild to moderate kidney disease may seriously diminish a child's quality of life.
A new peer-reviewed study published in Science Advances confirms the success of a new COVID-19 pooling test that identifies all positive subjects, including asymptomatic carriers, in a single round of testing.
A newly developed, genetically modified pig may hold the keys to the development of improved treatments and possibly even a cure for retinitis pigmentosa (RP), the most common inherited retinal disease in the United States.
In a departure from other industry polls, employers said they plan to reject private exchanges as a way to control rising health care costs, according to a new survey of more than 330 employers conducted by the non-profit National Business Coalition on Health and Benz Communications.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that its collaborator Genentech, a member of the Roche Group, has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking sales and marketing approval for vismodegib to treat people with advanced basal cell carcinoma (BCC), which includes metastatic and locally advanced BCC for whom surgery is inappropriate.
› Verified 1 days ago
Nishad Avinash Barve, Infectious Disease Medicare: Medicare Enrolled Practice Location: 1320 Mercy Dr Nw, Canton, OH 44708 Phone: 330-489-1000 | |
Todd L Johnson, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4466 Fulton Dr Nw, Canton, OH 44718 Phone: 330-489-1386 Fax: 330-489-1258 | |
John C Tsai, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4466 Fulton Dr Nw, Canton, OH 44718 Phone: 330-489-1386 Fax: 330-489-1258 | |
David Andrew Beard, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2600 6th St Sw, Canton, OH 44710 Phone: 330-363-2180 | |
Yara Khouri, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2600 Sixth St Sw, Canton, OH 44710 Phone: 330-363-6235 | |
Dr. Mitchell Haut, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1455 Harrison Ave Nw, Ste 105, Canton, OH 44708 Phone: 330-453-9993 Fax: 330-453-9996 | |
Ramana Podugu, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2600 6th St Sw, Suite A2-710, Canton, OH 44710 Phone: 330-454-8076 Fax: 330-454-3927 |